[Efficacy and safety of intrapleural fibrinolysis in pleural infection. Real-life study over 10 years in a university hospital] [0.03%]
胸腔内纤溶治疗感染性胸膜炎的疗效和安全性：大学医院10年真实世界研究
V Roy,V Bironneau,L Guerin et al.
V Roy et al.
Introduction: Intrapleural fibrinolysis has proved effective in reducing the length of hospital stay and the need for surgery in pleural infection. However, it carries risks, and its use in France remains unsystematic. Th...
[Resistance to immunotherapy in non-small cell lung cancer: State of the art] [0.03%]
非小细胞肺癌免疫治疗耐药现状及应对策略
J Ancel,M Dewolf,B Nawrocki-Raby et al.
J Ancel et al.
Introduction: Non-small cell lung cancer (NSCLC) remains one of the leading causes of cancer-related mortality worldwide. Immunotherapy has significantly reshaped its treatment, leading to improved survival in a subset of...
[Attitudes towards inhaled therapy in Algeria: Initial refusal and reluctant acceptance] [0.03%]
[阿尔及利亚吸入治疗的态度：最初拒绝和勉强接受]
R S Benazzouz,M Benyagoub,M S Benazzouz et al.
R S Benazzouz et al.
Objective: To estimate the frequency of initial refusal of inhaled treatment in Algerian pneumology outpatients and to describe the characteristics of patients presenting this refusal. ...
[Observance of antifibrotic treatment in the French OPALE support program for patients with pulmonary fibrosis] [0.03%]
法国OPALE项目中肺纤维化患者的抗纤维化治疗依从性观察
S Jouneau,G Prévot,A Constantin et al.
S Jouneau et al.
Introduction: The OPALE program has been designed to bolster observance of antifibrotic treatments in patients with diffuse interstitial lung disease (ILD). The effectiveness of these treatments depends largely on therape...
[Beyond pulmonary function: toward personalized work ability assessment in sarcoidosis] [0.03%]
[超越肺功能：探索个性化评估肉瘤病工作能力的方法]
M Drent,D Israël-Biet
M Drent
Sarcoidosis is a systemic inflammatory disease characterized by heterogeneous organ involvement and an unpredictable clinical course. Although clinical assessment often focuses on objective measures of disease activity, many patients experi...
C Menigoz,J Huet,S Dirou
C Menigoz
Introduction: Frailty is a complex and multidimensional clinical syndrome characterized by decreased physiological reserves. It, results in increased susceptibility to adverse health outcomes. In 2001, Fried et al. establ...
[Indications and modalities of non-standard inhaled treatments for respiratory pathologies: A narrative review] [0.03%]
非常规吸入疗法在呼吸系统疾病中的应用及模式——综述
L Frisson,G Reychler
L Frisson
Inhaled treatments represent a pillar in pneumology management, especially insofar as they allow for optimal local delivery of therapeutic agents. In addition to bronchodilators and corticosteroids, numerous inhalation-based treatments exis...
I Annesi-Maesano,P Bonniaud,G Bouchaud et al.
I Annesi-Maesano et al.
[Role of informal carers in chronic respiratory diseases: A French survey] [0.03%]
慢性呼吸系统疾病患者中的非正式照顾者角色——法国调查结果
S Gephine,F Le Guillou,P Tieghem et al.
S Gephine et al.
[Adherence to lung cancer screening by low-dose chest CT: Results of the first round of screening in the Multicenter Interventional DeCanPHaR Study] [0.03%]
低剂量胸部CT肺癌筛查依从性及首轮筛查结果——多中心干预研究DeCanPHaR项目报告
P Strentz,F Rinaldo,C Jacquet-Pierroulet et al.
P Strentz et al.
Introduction: In 2022, the French National Health Authority launched a task force for experimentation of low-dose chest CT screening in patients at high risk of lung cancer. In 2023, a study was conducted in the Haut-Rhin...